Teit E. Johansen
16Patents
6h-index
13Co-inventors
59Inventor score
Filing activity: Jul 2, 1999 → May 8, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6593133B1 | Neurotrophic factors | Human Necessities | 20 | Expired |
| US6734284B1 | Neublastin neurotrophic factors | Human Necessities | 18 | Expired |
| US7276580B2 | Neurotrophic factors | Human Necessities | 12 | Expired |
| US7358228B2 | Methods of treating pain using neurotrophic factors | Human Necessities | 11 | Active |
| US7655463B2 | Methods of activating RET receptor tyrosine kinase using neurotrophic factors | Human Necessities | 11 | Active |
| US8404642B2 | Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain | Human Necessities | 6 | Active |
| US8334264B2 | Therapeutic use of a growth factor, METRNL | Human Necessities | 6 | Active |
| US8217146B2 | Neurotrophic factors and methods of use thereof | Human Necessities | 2 | Active |
| US9068015B2 | Therapeutic use of a growth factor, METRNL | Human Necessities | 2 | Active |
| US8815810B2 | Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain | Human Necessities | 1 | Active |
| US9845344B2 | Therapeutic use of a growth factor, NsG33 | Chemistry; Metallurgy | 0 | Active |
| US9675669B2 | Therapeutic use of a growth factor, METRNL | Human Necessities | 0 | Active |
| US9861682B2 | Treatment of hyperalgesia, spontaneous pain, and phantom pain | Human Necessities | 0 | Active |
| US10034918B2 | Therapeutic use of a growth factor, METRNL | Human Necessities | 0 | Active |
| US9314502B2 | Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain | Human Necessities | 0 | Active |
| US9474786B2 | Treatment of allodynia | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.